See more comments To view or add a comment, sign in More Relevant Posts GLP-1 agonists are not cost-effective compared to gastric bypass for patients with severe obesity if current drug pricing persists, with an incremental cost-effectiveness ratio exceeding $500,000 per QALY over 10 years
Dizziness may occur, particularly if rapid weight loss leads to postural hypotension or if patients are concurrently taking antihypertensive medications that require dose adjustment
As a result, weve had a decade of efficiency gains absorbed by newly integrated hospital systems, pharmacy benefit managers, and expansive revenue-management bureaucracies
Identification and clarification of the role of key active site residues in bacterial glutathione S-transferase zeta/maleylpyruvate isomerase
Moreover, a large-scale randomized controlled trial (RCTs) involving more than 17,000 individuals with obesity and cardiovascular disease demonstrated that semaglutide reduced the risk of cardiovascular death, myocardial infarction (MI), and stroke compared to the placebo 9